Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Agile Therapeutics Inc. sell StockNews.com

Start price
€0.21
11.09.24 / 50%
Target price
-
11.09.25
Performance (%)
-
End price
-
12.09.25
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Agile Therapeutics Inc. - - -
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by StockNews_com for this prediction

In the thread Agile Therapeutics Inc. diskutieren

Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AGRX provided by MarketBeat

In the thread Trading Agile Therapeutics Inc.
Prediction Sell
Perf. (%) -
Target price
Change
Ends at 11.09.25

Die von StockNews_com gewählte maximale Laufzeit wurde überschritten

Stopped prediction by StockNews_com for Agile Therapeutics Inc.

Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
26.08.24
-
26.08.25
-
27.08.25

Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
18.08.24
-
18.08.25
-
19.08.25

Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
10.08.24
-
10.08.25
-
11.08.25

Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
01.07.24
-
01.07.25
-
02.07.25

Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
23.06.24
-
23.06.25
-
24.06.25

Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
15.06.24
-
15.06.25
-
16.06.25

Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
28.04.24
-
28.04.25
-
29.04.25

Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
20.04.24
-
20.04.25
-
21.04.25